Agnes Salamon
Primary Care · New Brunswick, NJNPI 1831578806
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,699 of the $5,296 with a category attached, or 88.7%. It is spread thinly across 34 manufacturers, the largest accounting for just 13.0% — the pattern of someone who eats at a lot of different presentations. Among primary care clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 280 payments — averaging $18.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$690
- Amgen$577
- Daiichi Sankyo Inc.$532
- Novartis$453
- E.r. Squibb & Sons, L.L.C.$384
- Sanofi$383
- plus $2K from 28 others
What the payments were for
- Food & beverage$4,69989%
- Education$59711%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 35 | $690 |
| Amgen | 23 | $577 |
| Daiichi Sankyo Inc. | 32 | $532 |
| Novartis | 31 | $453 |
| E.r. Squibb & Sons, L.L.C. | 25 | $384 |
| Sanofi | 19 | $383 |
| Seagen Inc. | 10 | $335 |
| Mirati Therapeutics, Inc. | 17 | $272 |
| Astellas Pharma US Inc | 10 | $268 |
| AbbVie | 8 | $201 |
| GSK | 11 | $184 |
| Pfizer | 6 | $112 |
| Lilly USA, LLC | 6 | $112 |
| Taiho Oncology, Inc. | 5 | $86 |
| Genentech USA, Inc. | 6 | $86 |
| Merck | 5 | $80 |
| Karyopharm Therapeutics Inc. | 5 | $75 |
| Bristol Myers Squibb | 3 | $63 |
| AstraZeneca(2 entities) | 3 | $59 |
| EMD Serono, Inc. | 3 | $49 |
| Servier Pharmaceuticals LLC | 3 | $47 |
| Incyte Corporation | 2 | $27 |
| Tersera Therapeutics LLC | 1 | $24 |
| Bayer | 1 | $22 |
| Genmab U.S., Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Cumberland Pharmaceuticals, Inc. | 1 | $19 |
| Biocon Biologics Inc | 1 | $19 |
| Argenx US, Inc. | 1 | $17 |
| Geron Corporation | 1 | $17 |
| Urogen Pharma, Inc. | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $15 |
| Boehringer Ingelheim | 1 | $14 |
How this compares
$5,296 in reported general payments places this provider in the 90th percentile of 330 primary care providers in New Jersey.
Other primary care in New Brunswick
- Elizabeth RamirezNew Brunswick$3K
- Michael Zito GovertNeptune$61K
- Roseann BenantiEnglewood$24K
- Marcelo MarinEnglewood$17K
- Jennifer EdwardsPrinceton$14K
- Mary Grace TolentinoJersey City$9K
- Kevin Robert ReyladoNorth Arlington$8K
- Carlo SebelloJersey City$8K
- Karam WehbehPaterson$7K
- Shazam BacchusNewark$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.